Connection

Jinghua Yan to Protein Multimerization

Back to Details
This is a "connection" page, showing publications Jinghua Yan has written about Protein Multimerization.
Jinghua Yan
Connection Strength
0.092
Protein Multimerization
  1. Safety and immunogenicity of a recombinant tandem-repeat dimeric RBD-based protein subunit vaccine (ZF2001) against COVID-19 in adults: two randomised, double-blind, placebo-controlled, phase 1 and 2 trials. Lancet Infect Dis. 2021 08; 21(8):1107-1119.
    View in: PubMed
    Score: 0.035
  2. Limited Cross-Linking of 4-1BB by 4-1BB Ligand and the Agonist Monoclonal Antibody Utomilumab. Cell Rep. 2018 10 23; 25(4):909-920.e4.
    View in: PubMed
    Score: 0.030
  3. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat Commun. 2017 04 10; 8:15092.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.